Buy Day today: Good (67) Broad market participation · no major macro event

Bioventus Inc (BVS)

Healthcare Medical Devices

13.50 $

+2.3% vs. previous close

Closing price · As of: 3. Aug 2026

Bioventus Inc (BVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 651 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet BVS
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	837	811	811	794	792	769	728	691	707	702	684	651
Current Assets	261	249	268	266	309	299	276	249	275	281	273	250
Cash	29	27	37	25	32	43	42	23	33	42	51	36
Cash & Short-Term Investments	29	27	37	25	32	43	42	23	33	42	51	36
Receivables	120	113	123	126	137	122	127	118	132	130	128	121
Inventory	96	98	91	97	88	90	92	94	96	96	82	83
Property, Plant & Equipment	57	–	–	–	–	–	–	–	–	–	–	–
Goodwill	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5
Intangible Assets	505	493	482	471	425	415	405	396	387	377	368	360
Total Liabilities	604	585	590	577	603	583	542	506	505	494	455	416
Current Liabilities	179	161	175	173	231	211	210	175	186	162	160	148
Short-Term Debt	11	20	28	36	39	39	27	37	43	11	19	19
Accounts Payable	41	18	23	19	24	17	24	19	24	27	11	24
Long-Term Debt	375	375	367	355	345	345	308	309	298	311	279	253
Shareholders' Equity	183	178	174	171	151	149	148	148	161	166	184	189
Retained Earnings	-308	-315	-322	-326	-350	-355	-355	-360	-353	-350	-335	-332
Shares Outstanding	63	63	63	63	64	65	65	66	69	69	69	70

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings